# contextual query Endothelial (venule)

Query: The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ABCB1', 'VWF', 'EPAS1', 'PLEKHG1', 'FLT1', 'RBMS3', 'MECOM', 'ERG', 'PTPRG', 'ANO2']

The enrichment of the genes **ABCB1, VWF, EPAS1, PLEKHG1, FLT1, RBMS3, MECOM, ERG, PTPRG,** and **ANO2** in vascular-associated cells from a glioblastoma microenvironment provides important information about the **state, properties, and interactions** of this cell population. Analysis of both cancer and non-cancer contexts reveals several key themes:

**1. Vascular Endothelial Identity and Angiogenic Signaling**
- **VWF (von Willebrand factor)** is a classical marker of endothelial cells, essential for blood coagulation and an indicator of mature vasculature.
- **FLT1 (VEGFR1)** and **EPAS1 (HIF-2α)** are central to angiogenesis:
  - **FLT1** encodes VEGF receptor-1, directly mediating responses to VEGF signals, thus enabling formation of new vessels and adaptation to hypoxia.
  - **EPAS1** drives gene expression in response to low oxygen, upregulating angiogenic factors and supporting vessel growth.
- **ERG** is a transcription factor crucial for endothelial differentiation, vessel stability, and homeostasis.
- The presence of these genes indicates active **angiogenic programs**, typical of both developing tissues and tumors like glioblastoma, which are highly vascularized[1][2].

**2. Cellular Plasticity and Developmental Parallels**
- Genes such as **RBMS3** and **MECOM** are implicated in vascular development and endothelial plasticity.
  - **RBMS3** is linked to endothelial cell proliferation and vessel formation during embryonic development.
  - **MECOM** (EVI1) has roles in hematopoiesis and may influence the behavior of perivascular stromal cells.
- The reactivation of developmental pathways in glioblastoma vasculature mirrors processes seen in embryogenesis[3].

**3. Barrier and Transport Properties**
- **ABCB1 (MDR1)** encodes P-glycoprotein, a transporter highly expressed at the blood-brain barrier (BBB) and in tumor vessels.
  - Its enrichment suggests these vascular cells may contribute to **drug resistance by actively effluxing therapeutic compounds**, a key challenge in GBM treatment.
- **ANO2** codes for a calcium-activated chloride channel that may participate in endothelial cell volume regulation or signaling, though its specific role in the vasculature requires further elucidation.

**4. Cell-Cell and Immune Interactions**
- **PTPRG** (a protein tyrosine phosphatase) is involved in cell signaling and has been described as a tumor suppressor; it may modulate endothelial–immune or endothelial–tumor cell contacts.
- Endothelial cells often coordinate cross-talk with immune cells in both tumors and normal tissues, influencing immune cell recruitment and the inflammatory milieu[4].

**5. Vascular Remodeling and Cellular Interactions**
- **PLEKHG1** is involved in cytoskeletal rearrangement and cell migration, supporting endothelial sprouting and vessel adaptation to the tumor microenvironment.
- The gene set includes regulators of cell motility, suggesting these vascular-associated cells are not static, but may be actively **remodeling vasculature** for tumor support.

**6. General Metabolic and Environmental Adaptation**
- The upregulation of **hypoxia response genes** (e.g., EPAS1) signals adaptation to the low oxygen often found in tumors, driving metabolic reprogramming and encouraging glycolytic metabolism, a hallmark of both cancer and rapidly growing normal tissues.

**Summary Table: Key Gene Functions in Vascular-Associated Cells**

| Gene     | Principal Function                    | Relevance to Vasculature and TME             |
|----------|--------------------------------------|----------------------------------------------|
| VWF      | Coagulation, endothelial marker      | Maturity, vessel stability                   |
| FLT1     | VEGF receptor, angiogenesis          | Response to VEGF, vessel growth              |
| EPAS1    | Hypoxia response, angiogenesis       | Adaptation to low O₂, VEGF expression        |
| ERG      | Endothelial transcription factor     | Differentiation, stability                   |
| ABCB1    | Drug efflux transporter              | BBB, chemoresistance                         |
| MECOM    | Developmental/hematopoietic regulator| Cellular plasticity, pericyte potential      |
| RBMS3    | RNA binding, proliferation           | Vessel development                           |
| PLEKHG1  | Cytoskeletal dynamics                | Endothelial migration, remodeling            |
| PTPRG    | Signal transduction                  | Cell-cell interaction, potential tumor suppression |
| ANO2     | Chloride channel                     | Ion signaling, cell volume regulation        |

**Conclusion**

These genes collectively indicate a **vascular cell phenotype** that is
- Highly **angiogenic**
- Adapted to the **tumor environment** (hypoxic, metabolically active)
- Contributing to **barrier function and drug resistance**
- Engaged in **dynamic remodeling** and **interaction with other cell types** (e.g., immune, stromal, tumor cells)

Many of these features recapitulate normal vascular development and homeostasis but are co-opted and amplified in the context of glioblastoma, supporting both tumor growth and resistance to therapy[1][2][3][4].



## References

- [1] MicroRNA‑566 modulates vascular endothelial growth factor by targeting Von Hippel‑Landau in human glioblastoma in vitro and in vivo. https://www.spandidos-publications.com/10.3892/mmr.2015.4537 None None
- [2] The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.4248 2015-06-04 None
- [3] Human BCAS3 Expression in Embryonic Stem Cells and Vascular Precursors Suggests a Role in Human Embryogenesis and Tumor Angiogenesis https://dx.plos.org/10.1371/journal.pone.0001202 2007-11-21 None
- [4] Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics https://www.frontiersin.org/articles/10.3389/fimmu.2023.1288137/full 2024-01-11 None
- [5] SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphia http://biorxiv.org/lookup/doi/10.1101/2021.04.12.438457 2021-04-12 None